MedPath

The efficacy and safety of prednisolone in the prevention of re-accumulation of ascites among endomyocardial fibrosis (EMF) patients at Mulago hospital

Not Applicable
Completed
Conditions
Endomyocardial fibrosis
Circulatory System
Endomyocardial (tropical) fibrosis
Registration Number
ISRCTN63999319
Lead Sponsor
Makerere University College of Health Sciences (Uganda)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria

1. Age: 13 years and older, either sex
2. Patients with a diagnosis of endomyocardial fibrosis and ascites
3. For patients already on corticosteroids a wash out period of 1month will be allowed before recruitment into the trial
4. Consent/ assent to participate in the trial

Exclusion Criteria

1. Critically ill patients with unstable vital parameters
2. Use of corticosteroids within the previous month for other indications
3. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath